Identification of an immunomodulatory lncRNA signature associated with immune cell reprogramming in high-grade glioma. [PDF]
Canella A, Rajappa P.
europepmc +1 more source
Diagram of the reprogramming of FA metabolism mediated by LDHC4‐induced ACAA2 activity to promote TNBC progression. LDHC4 drives TNBC progression by enhancing ACAA2‐mediated fatty acid production. The resulting accumulation of FFAs stimulates autophagy and accelerates cell cycle progression, thereby promoting tumor growth.
Zhaolei Cui+10 more
wiley +1 more source
Causal relationships between gut microbiota and urothelial carcinoma mediated by inflammatory cytokines and blood cell traits identified through Mendelian randomization analysis. [PDF]
Wu X, Zou W, Liu Z.
europepmc +1 more source
In patients after gastric cancer surgery, low postoperative PNI values, considering nutritional status, surgical stress, and postoperative inflammatory response, were significantly associated with poor prognosis in terms of both RFS and OS. ABSTRACT Aim To verify whether postoperative prognostic nutritional index is a useful prognostic factor in ...
Masaaki Yamamoto+9 more
wiley +1 more source
PRMT1 promotes immune escape in hepatocellular carcinoma by regulating arginine methylation modification of MYC protein. [PDF]
Zhou H+5 more
europepmc +1 more source
The key to unlocking ICI benefit in pMMR/MSS LARC is to convert “cold” tumors into “hot” ones through lymphocyte‐sparing SCRT and judicious chemotherapy, creating a milieu in which ICIs can act effectively. ABSTRACT The management of locally advanced rectal cancer (LARC) has evolved with the adoption of total neoadjuvant therapy (TNT), integrated ...
Yoshinori Kagawa+5 more
wiley +1 more source
The DCDC2/ENO1 axis promotes tumor progression and immune evasion in intrahepatic cholangiocarcinoma via activating FGL1-LAG3 checkpoint. [PDF]
Wan W+7 more
europepmc +1 more source
Target - The Elderly: A Nondiscrimination Perspective on Daniel Callahan\u27s Setting Limits [PDF]
Destro, Robert A.
core +1 more source
Harnessing the Biological Responses Induced by Nanomaterials for Enhanced Cancer Therapy
Nanomaterial (NM)‐induced toxicity can be strategically repurposed for cancer therapy. This review summarizes the mechanism by which NMs selectively activate specific cellular processes to regulate cell fate independently. We also discussed how NMs‐induced biological responses can be leveraged as therapeutic strategies for cancer treatment.
Liting Wang+6 more
wiley +1 more source